Business Description
MyMD Pharmaceuticals Inc
NAICS : 541713
SIC : 2833
ISIN : US62856X1028
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 48.19 | |||||
Equity-to-Asset | 0.69 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -16.6 | |||||
3-Year EPS without NRI Growth Rate | -19.4 | |||||
3-Year FCF Growth Rate | -30.7 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 4.12 | |||||
9-Day RSI | 13.77 | |||||
14-Day RSI | 23.05 | |||||
6-1 Month Momentum % | -66.9 | |||||
12-1 Month Momentum % | -95.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.62 | |||||
Quick Ratio | 0.62 | |||||
Cash Ratio | 0.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.7 | |||||
Shareholder Yield % | 1.79 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -98.7 | |||||
ROA % | -56.98 | |||||
ROIC % | -133.27 | |||||
ROC (Joel Greenblatt) % | -21381.48 | |||||
ROCE % | -97.16 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.4 | |||||
EV-to-EBIT | -0.16 | |||||
EV-to-EBITDA | -0.16 | |||||
EV-to-FCF | -0.25 | |||||
Earnings Yield (Greenblatt) % | -625 | |||||
FCF Yield % | -254.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MyMD Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -9.57 | ||
Beta | 1.08 | ||
Volatility % | 60.7 | ||
14-Day RSI | 23.05 | ||
14-Day ATR ($) | 0.036596 | ||
20-Day SMA ($) | 1.976585 | ||
12-1 Month Momentum % | -95.33 | ||
52-Week Range ($) | 1.79 - 61.8 | ||
Shares Outstanding (Mil) | 2.37 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MyMD Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MyMD Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
MyMD Pharmaceuticals Inc Frequently Asked Questions
What is MyMD Pharmaceuticals Inc(LTS:0A8D)'s stock price today?
When is next earnings date of MyMD Pharmaceuticals Inc(LTS:0A8D)?
Does MyMD Pharmaceuticals Inc(LTS:0A8D) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |